TuHURA Biosciences Discovery Research on Targeting the Delta Opioid Receptor (DOR) to Reprogram Myeloid-Derived Suppressor Cells (MDSCs) Selected for Oral Presentation at the 67th ASH Annual Meeting and Exposition

Verdict

Headline takes no side. We score HURA +0.80 — strongly bullish.

Headline says

No call

No rating or direction in the headline

Expected · HURA

+0.80strongly bullish

−1 bearish0bullish +1

More positive than 88% of ticker scores this week